首页> 外文期刊>Therapeutic Drug Monitoring >Predictive performance study of two digoxin assays in subjects with various degrees of renal function.
【24h】

Predictive performance study of two digoxin assays in subjects with various degrees of renal function.

机译:两种地高辛试验在不同程度肾功能患者中的预测性能研究。

获取原文
获取原文并翻译 | 示例
       

摘要

This prospective study was conducted to compare the predictive performance of fluorescence polarization immunoassay (FPIA, Abbott TDx Digoxin II) and radioimmunoassay (RIA, Kallestad Labs) with combined low-pressure liquid chromatography/RIA (LPLC/RIA) digoxin assay in measuring 15-17 serum digoxin concentrations (SDC) obtained after a single 10 microg/kg intravenous digoxin dose in patients with various degrees of renal function and at different SDC ranges. Eighteen men and women were stratified into 3 age- and gender-matched groups based upon renal function [N = 6 in each, group I (Cl(cr) < 10 mL/min), group II (Cl(cr) = 10-50 mL/min), and group III (Cl(cr) > 50 mL/min)]. Serum digoxin concentrations were measured at time zero; at 0.25, 0.5, 0.75, 1, 2, 3, 4, 6, 8, and 12 hours; and at 2, 3, 4, and 5-7 days after the digoxin dose, using the three different digoxin assays. TDx Digoxin II was unbiased [mean error -0.09 (95% CI -0.19, 0.01)] and RIA biased [mean error -0.29 (95% CI -0.36, -0.21)] to over-predict SDC by 14.2%. In group I patients, the analysis revealed a bias to over-predict SDC by 6.0% for TDx Digoxin II [mean error -0.16 (95% CI -0.29, -0.07)] and an unbiased performance by RIA. In groups II and III, both TDx Digoxin II and RIA showed biased performance, the mean magnitude of bias was low (< 20%). For intermediate SDC range (> 0.5 ng/mL and < or = 3.0 ng/mL), TDx Digoxin II was unbiased in predicting SDC, whereas RIA was biased to under-predict SDC [mean error 0.13 (95% CI 0.10, 0.16)] by 9.9%. The magnitude of bias observed in all cases was less than 20%. Both assays, TDx Digoxin II and RIA, imprecisely measured SDC for all samples combined, different groups and SDC ranges. In all time-paired samples, TDx Digoxin II (FPIA) performed better than the RIA. In conclusion, the magnitude of bias observed with either assay at different groups and SDC ranges was not likely to be clinically relevant. Therefore, either assay may be used to measure SDC in clinical practice.
机译:进行了这项前瞻性研究,以比较荧光偏振免疫测定法(FPIA,Abbott TDx Digoxin II)和放射免疫测定法(RIA,Kallestad Labs)与低压液相色谱/ RIA(LPLC / RIA)地高辛测定法在15-肾功能不同程度和SDC范围不同的患者,单次静脉注射10 mg / kg地高辛剂量后获得的17种血清地高辛浓度(SDC)。根据肾功能,将18位男女分为3个年龄和性别匹配的组[N = 6,第一组(Cl(cr)<10 mL / min),第二组(Cl(cr)= 10- 50 mL / min)和第III组(Cl(cr)> 50 mL / min)]。在零时测量血清地高辛浓度。在0.25、0.5、0.75、1、2、3、4、6、8和12小时;使用三种不同的地高辛测定法,在地高辛给药后第2、3、4和5-7天。 TDx地高辛II无偏[平均误差-0.09(95%CI -0.19,0.01)]和RIA有偏向[平均误差-0.29(95%CI -0.36,-0.21)]高估了SDC 14.2%。在第一组患者中,分析显示TDx地高辛II的SDC高估了6.0%[平均误差-0.16(95%CI -0.29,-0.07)],RIA的表现无偏倚。在第II组和第III组中,TDx地高辛II和RIA均表现出有偏差的性能,平均偏差幅度较低(<20%)。对于中等SDC范围(> 0.5 ng / mL且<或= 3.0 ng / mL),TDx地高辛II在预测SDC时没有偏见,而RIA偏向于预测不足的SDC [平均误差0.13(95%CI 0.10,0.16) ]的9.9%。在所有情况下,观察到的偏差幅度均小于20%。 TDx地高辛II和RIA两种检测方法均无法准确地测量所有组合样品,不同组和SDC范围的SDC。在所有时间配对的样品中,TDx地高辛II(FPIA)的性能均优于RIA。总之,在不同组和SDC范围内使用任一种测定法观察到的偏差幅度在临床上均无相关性。因此,在临床实践中,任何一种测定都可以用于测量SDC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号